Financial And Healthcare Markets And AI Will Expand Opportunities

AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Published
02 Apr 25
Updated
08 Aug 25
AnalystConsensusTarget's Fair Value
US$6.85
60.1% undervalued intrinsic discount
08 Aug
US$2.73
Loading
1Y
-39.5%
7D
-11.7%

Author's Valuation

US$6.9

60.1% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Increased 23%

Shared on24 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Decreased 19%

AnalystConsensusTarget has decreased revenue growth from -4.6% to -5.4%, decreased profit margin from 2.4% to 0.7%, increased future PE multiple from 10.2x to 28.0x and increased shares outstanding growth rate from 0.0% to 0.0%.